Vir Biotechnology, Inc. SEC filings VIR

Vir Biotechnology, Inc. has 801 filings in SEC EDGAR's recent list, going back to Jun 29, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Vir Biotechnology, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Officer or director change
Oct 28, 2026 Oct 26, 2026
8-K Current report
Unregistered share sale, Other events
Oct 14, 2026 Oct 9, 2026
8-K Current report
Other events
Oct 8, 2026 Oct 8, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 1, 2026 Oct 1, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Officer or director change
Jul 24, 2026 Jul 20, 2026
8-K Current report
Officer or director change
Jun 10, 2026 Jun 9, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 28, 2026 May 25, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
ARS Annual report to shareholders Apr 16, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 16, 2026 —
DEF 14A Proxy statement Apr 16, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Apr 10, 2026 Apr 7, 2026
8-K Current report
Officer or director change
Mar 4, 2026 Mar 4, 2026
8-K Current report
Other events
Mar 2, 2026 Feb 26, 2026
8-K Current report
Material agreement
Feb 26, 2026 Feb 25, 2026
424B5 Prospectus supplement Feb 26, 2026 —
424B5 Prospectus supplement Feb 24, 2026 —
S-8 Employee stock plan registration Feb 23, 2026 —
10-K Annual report Feb 23, 2026 Dec 31, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Other events
Feb 23, 2026 Feb 19, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Material agreement, Other events
Dec 16, 2025 Dec 16, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Other events
Jul 24, 2025 Jul 24, 2025
8-K Current report
Shareholder vote results
May 29, 2025 May 29, 2025
8-K Current report
Other events
May 9, 2025 May 9, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 17, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 17, 2025 —
DEF 14A Proxy statement Apr 17, 2025 May 29, 2025
S-8 Employee stock plan registration Feb 27, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
8-K Current report
Officer or director change
Jan 30, 2025 Jan 24, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 8, 2025 Jan 8, 2025
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024
8-K Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
Sep 10, 2024 Sep 6, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Results of operations, Exit or restructuring costs
Aug 1, 2024 Jul 29, 2024
8-K Current report
Material agreement
Aug 1, 2024 Jul 31, 2024
8-K Current report
Other events
Jun 26, 2024 Jun 26, 2024
8-K Current report
Regulation FD disclosure
Jun 5, 2024 Jun 5, 2024
8-K Current report
Shareholder vote results
May 29, 2024 May 29, 2024
DEFA14A Additional proxy material May 14, 2024 —
10-Q Quarterly report May 3, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 2, 2024 May 2, 2024
ARS Annual report to shareholders Apr 19, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 19, 2024 —
DEF 14A Proxy statement Apr 19, 2024 May 29, 2024
8-K Current report
Officer or director change, Other events
Apr 18, 2024 Apr 15, 2024
S-8 Employee stock plan registration Feb 26, 2024 —
10-K Annual report Feb 26, 2024 Dec 31, 2023
8-K Current report
Material agreement, Results of operations
Feb 22, 2024 Feb 21, 2024
8-K Current report
Officer or director change
Feb 20, 2024 Feb 19, 2024
8-K Current report
Exit or restructuring costs
Dec 13, 2023 Dec 13, 2023
8-K Current report
Material agreement, Agreement ended
Nov 3, 2023 Nov 3, 2023
S-3ASR Automatic shelf registration Nov 3, 2023 —
10-Q Quarterly report Nov 3, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Material agreement
Oct 3, 2023 Oct 3, 2023
8-K Current report
Officer or director change
Sep 20, 2023 Sep 19, 2023
10-Q Quarterly report Aug 4, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Results of operations, Other events
Jul 20, 2023 Jul 20, 2023
8-K Current report
Shareholder vote results
May 23, 2023 May 19, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 7, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 7, 2023 —
DEF 14A Proxy statement Apr 7, 2023 —
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
8-K Current report
Bylaw or fiscal year change
Mar 8, 2023 Mar 2, 2023
S-8 Employee stock plan registration Feb 28, 2023 —
10-K Annual report Feb 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
8-K Current report
Other events
Feb 22, 2023 Feb 21, 2023
8-K Current report
Officer or director change
Feb 16, 2023 Feb 13, 2023
8-K Current report
Material agreement
Feb 13, 2023 Feb 8, 2023
8-K Current report
Officer or director change
Jan 25, 2023 Jan 19, 2023
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Other events
Oct 4, 2022 Sep 28, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
8-K Current report
Other events
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
Jul 14, 2022 Jul 11, 2022
8-K Current report
Material agreement
Jun 3, 2022 May 27, 2022
8-K Current report
Shareholder vote results
May 24, 2022 May 20, 2022
8-K Current report
Material agreement, Agreement ended
May 20, 2022 May 16, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 7, 2022 —
DEF 14A Proxy statement Apr 7, 2022 May 20, 2022
8-K Current report
Officer or director change
Apr 7, 2022 Apr 4, 2022
8-K Current report
Other events
Apr 5, 2022 Apr 5, 2022
8-K Current report
Other events
Mar 25, 2022 Mar 25, 2022
S-8 Employee stock plan registration Feb 28, 2022 —
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Feb 24, 2022 Feb 24, 2022
8-K Current report
Material agreement, Agreement ended, New debt
Dec 22, 2021 Dec 16, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Other events
Sep 29, 2021 Sep 29, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Other events
Jun 28, 2021 Jun 21, 2021
8-K Current report
Other events
May 27, 2021 May 26, 2021
8-K Current report
Material agreement, Shareholder vote results
May 24, 2021 May 18, 2021
8-K Current report
Other events
May 21, 2021 May 21, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Other events
Apr 13, 2021 Apr 13, 2021
DEFA14A Additional proxy material Apr 6, 2021 —
DEF 14A Proxy statement Apr 6, 2021 May 20, 2021
8-K Current report
Other events
Mar 31, 2021 Mar 31, 2021
8-K Current report
Other events
Mar 30, 2021 Mar 26, 2021
S-8 Employee stock plan registration Feb 25, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Material agreement, Unregistered share sale
Feb 19, 2021 Feb 14, 2021
8-K Current report
Other events
Jan 28, 2021 Jan 26, 2021
8-K Current report
Material agreement
Jan 6, 2021 Dec 30, 2020
8-K Current report
Material agreement
Dec 29, 2020 Dec 24, 2020
8-K Current report
Officer or director change
Dec 10, 2020 Dec 10, 2020
8-K Current report
Material agreement
Nov 10, 2020 Nov 10, 2020
S-3ASR Automatic shelf registration Nov 10, 2020 —
10-Q Quarterly report Nov 10, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 10, 2020 Nov 10, 2020
8-K Current report
Other events
Sep 16, 2020 Sep 16, 2020
8-K Current report
Officer or director change
Sep 1, 2020 Aug 28, 2020
10-Q Quarterly report Aug 11, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 11, 2020 Aug 11, 2020
8-K Current report
Other events
Aug 7, 2020 Aug 4, 2020
424B4 Prospectus Jul 8, 2020 —
POS EX Filing Jul 8, 2020 —
EFFECT Filing Jul 7, 2020 —
S-1MEF Filing Jul 7, 2020 —
CORRESP Letter to the SEC Jul 6, 2020 —
CORRESP Letter to the SEC Jul 6, 2020 —
S-1 Registration statement Jul 6, 2020 —
8-K Current report
Officer or director change, Other events
Jul 6, 2020 Jul 2, 2020
UPLOAD Letter from the SEC Jun 29, 2020 —
DRS Filing Jun 23, 2020 —
8-K Current report
Material agreement, Other events
Jun 19, 2020 Jun 12, 2020
8-K Current report
Material agreement
Jun 15, 2020 Jun 9, 2020
8-K Current report
Material agreement
May 29, 2020 May 22, 2020
8-K Current report
Shareholder vote results
May 22, 2020 May 20, 2020
10-Q Quarterly report May 12, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 12, 2020 May 12, 2020
DEFA14A Additional proxy material May 8, 2020 —
D Filing May 8, 2020 —
D Filing May 8, 2020 —
8-K Current report
Other events
Apr 30, 2020 Apr 29, 2020
8-K Current report
Material agreement
Apr 10, 2020 Apr 9, 2020
8-K Current report
Material agreement
Apr 7, 2020 Apr 1, 2020
DEFA14A Additional proxy material Apr 6, 2020 —
DEF 14A Proxy statement Apr 6, 2020 May 20, 2020
8-K Current report
Material agreement, Unregistered share sale
Apr 6, 2020 Apr 5, 2020
S-8 Employee stock plan registration Mar 26, 2020 —
10-K Annual report Mar 26, 2020 Dec 31, 2019
8-K Current report
Results of operations
Mar 26, 2020 Mar 26, 2020
8-K Current report
Material agreement
Mar 9, 2020 Mar 3, 2020
8-K Current report
Other events
Feb 12, 2020 Feb 12, 2020
8-K Current report
Other events
Jan 30, 2020 Jan 29, 2020
8-K Current report
Other events
Jan 23, 2020 Jan 22, 2020
10-Q Quarterly report Nov 19, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 19, 2019 Nov 19, 2019
8-K Current report
Officer or director change, Bylaw or fiscal year change
Oct 16, 2019 Oct 10, 2019
S-8 Employee stock plan registration Oct 15, 2019 —
424B4 Prospectus Oct 11, 2019 —
EFFECT Filing Oct 10, 2019 —
CERT 8a certification Oct 10, 2019 —
8-A12B Filing Oct 9, 2019 —
CORRESP Letter to the SEC Oct 8, 2019 —
CORRESP Letter to the SEC Oct 8, 2019 —
CORRESP Letter to the SEC Sep 30, 2019 —
S-1/A Amended registration statement Sep 30, 2019 —
SEC STAFF LETTER Filing Sep 20, 2019 —
CORRESP Letter to the SEC Sep 17, 2019 —
UPLOAD Letter from the SEC Sep 10, 2019 —
CORRESP Letter to the SEC Sep 3, 2019 —
S-1 Registration statement Sep 3, 2019 —
UPLOAD Letter from the SEC Aug 26, 2019 —
DRSLTR Filing Aug 7, 2019 —
DRS/A Filing Aug 7, 2019 —
UPLOAD Letter from the SEC Jul 25, 2019 —
SEC STAFF LETTER Filing Jul 15, 2019 —
DRS Filing Jun 27, 2019 —
D Filing Jun 29, 2018 —

Showing 199 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VIR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1706431

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.